Copenhagen, Denmark

Miklos Diossy

This inventor holds 1 USPTO granted patent. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Miklos Diossy. Retrieved from https://idiyas.com/inventor/miklos-diossy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Miklos Diossy: Innovator in Cancer Treatment

Introduction

Miklos Diossy is a prominent inventor based in Copenhagen, Denmark. He has made significant contributions to the field of cancer treatment through his innovative research and development efforts. His work is particularly focused on methods that aim to improve patient outcomes in oncology.

Latest Patents

Miklos Diossy holds a patent for a groundbreaking invention titled "Method for Treating Cancer." This patent represents his commitment to advancing medical science and providing new solutions for cancer patients. He has 1 patent to his name, showcasing his dedication to innovation in this critical area.

Career Highlights

Miklos Diossy is affiliated with the Dana-Farber Cancer Institute, a leading organization in cancer research and treatment. His role at the institute allows him to collaborate with other experts in the field and contribute to cutting-edge research initiatives. His work has the potential to impact the lives of many individuals battling cancer.

Collaborations

Miklos has worked alongside notable colleagues, including Kent William Mouw and Judit Borcsok. These collaborations enhance the research environment and foster the exchange of ideas that can lead to further advancements in cancer treatment.

Conclusion

Miklos Diossy is a dedicated inventor whose work in cancer treatment exemplifies the spirit of innovation in medical research. His contributions are vital to the ongoing fight against cancer, and his patent reflects his commitment to improving patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…